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Breast MRI with DWIAbstract Purpose: To assess the impact of diffusion-weighted images as a complementary tool to
conventional breast MRI in the evaluation of various breast lesions.
Materials and methods: From November 2013 to June 2014 thirty patients referred from breast
clinic by breast symptoms and abnormal sono-mammography lesions have been included in this
study. All patients underwent breast DCE-MRI combined with DWI and the results were compared
with the histopathological examination which was used as the standard diagnostic method.
Results: The study included thirty patients complaining of breast lesions, 35 lesions were detected,
according to the histopathological analysis, there were 20 malignant lesions (57.14%) and 15 benign
lesions (42.86%). DCE-MRI had a sensitivity of 80%, a speciﬁcity of 73.33%, PPV of 80%, NPV of
73.3% and accuracy of 77.14%. The malignant lesions showed a mean ADC value of 1.03 ± 0.35.
Alternatively, the benign lesions showed a mean ADC value of 1.38 ± 0.26. Among the 20 malig-
nant lesions, 17 lesions showed an ADC value 61.20 mm2/s and 3 lesions showed an ADC value
>1.20 mm2/s. While among the 15 benign lesions, 14 lesions showed ADC value >1.20 mm2/s
and 1 lesion showed an ADC value 61.20. The ROC curve showed that the best ADC cut-off value
to differentiate between benign and malignant lesions was 1.2 mm2/s (P< 0.001) with sensitivity,
speciﬁcity, PPV, NPV and accuracy of 85%, 93.33%, 94.4%, 82.4% and 90.3% respectively.
Conclusion: DWI had a higher sensitivity and speciﬁcity than DCE-MRI with ADC cut off value
1.20. This value was a sensitive and speciﬁc parameter in differentiating benign and malignant
breast lesions.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Breast cancer is the most common female neoplasm (31% of
tumors in females), and the second-leading cause of death
among women. Breast lesions were ﬁrst classiﬁed as malignant
or benign categories (1). Further, the increasing rate of breasted.
260 W. Hettacancer continues to be a major area of concern for both clini-
cians and researchers. Increased awareness in the affected pop-
ulation leads to more frequent physical examinations and
diagnostic imaging procedures which results in earlier diagno-
sis and hence improved prognosis (2).
Mammography has been proven to detect breast cancer at
an early stage; other screening technologies also may contrib-
ute to the earlier detection of breast cancer, particularly in
women under the age of 40 years for whom mammography
is less sensitive such as breast ultrasound or MRI (3).
Breast ultrasound examination has been used for years as
an adjunct to mammography for evaluating palpable or mam-
mographically detected breast masses to determine if a lesion
represents a cyst or a solid mass (4).
Conventional mammography and ultrasound are known to
have high false positive rates in the detection of breast malig-
nancy (60–80%), resulting in unnecessary biopsies being per-
formed. So, MR techniques have shown strong potential to
improve the sensitivity and speciﬁcity in the diagnosis of breast
cancer (5).
Breast MRI has become an important tool for breast cancer
detection and characterization. Dynamic contrast-enhanced
MRI is highly sensitive for breast cancer, allowing detection
of malignancy that is occult on physical examination, mam-
mography, and sonography (6).
Breast MRI may be used to distinguish between benign and
malignant areas, this may reduce the number of breast biopsies
done to evaluate a suspicious breast mass. Although MRI can
detect tumors in dense breast tissue, it cannot detect tiny
specks of calcium (micro calciﬁcations), which account for half
of the cancers detected by mammography (7).
Typical breast MRI exams involve a contrast-enhanced scan
to highlight tissue with increased vascularity, very sensitive for
detectingmalignancies but alsoproducingmany false-positives (8).
DWI is a technique that involves the exchange of water
molecules (diffusion) between breast tissue compartments. Dif-
fusion rates vary between normal and pathologic tissue. The
value of diffusion of water in tissues is called apparent diffu-
sion coefﬁcient (ADC) and it is calculated in the MRI machine
by using ADC mapping. The studies showed that the ADC
varies between malignant and benign breast masses. So appli-
cation of DW sequence to the breast MRI will improve the
speciﬁcity of the MRI (9).
So using diffusion-weighted imaging (DWI) combined to
MRI is helpful to distinguish malignant versus benign breast
lesions and it also may reduce the number of unnecessary
breast biopsies (10).
2. Patients and methods
From November 2013 to June 2014, thirty patients have been
included in this study, the patients’ age ranges from 24 to
76 years with mean age of 47 ± 10.5.
2.1. Inclusion criteria
1. Female gender.
2. Age more than 18 years old.
3. Patients with newly discovered breast symptoms.
4. Patients with recurrent breast cancer following chemother-
apy or radiotherapy sessions.2.2. Exclusion criteria
1. Male gender.
2. Patient with recent breast trauma in the same diseased
breast within the last 6 months.
3. Contraindication to perform MRI examination. These
include:
– Cardiac pacemaker.
– Metallic aneurysm clips.
The patients underwent full history taking and dedicated
general and local examination. All patients underwent breast
MRI examination and the results of breast MRI were com-
pared with the histopathological examination which was used
as the standard diagnostic method.
2.3. MR imaging protocol
Dynamic contrast enhanced MRI was performed with high
ﬁeld strength 1.5 Tesla MR Systems using dedicated double
breast coil. DWI was performed before the DCE-MRI acqui-
sition using a diffusion-weighted echo-planar imaging (EPI)
sequence with parallel imaging. A bolus of gadolinium was
injected intravenous by a pump at a dose of 0.1 mmol/kg.
Dynamic T1 WIs were then performed using gradient echo
T1 weighted image with fat suppression (STIR).
2.4. Image post processing on the workstation
A region of interest was deﬁned for each DCE-MRI-detected
lesion at the corresponding location on the combined DWI
(SDWI) series. The mean ADC of the voxels in the ROI was cal-
culated for each lesion. Quantitative analysis was done pre-
sented in automatically created time/signal intensity curve.2.5. MRI image interpretation
STIR images were ﬁrst examined to detect the presence or
absence of lesion enhancement.
In case of lesion enhancement the corresponding non sub-
tracted pre-contrast and post contrast images in each time
point were viewed together and lesion interpretation took
place whether it a focus, mass or non mass like enhancement.
In case of mass enhancement evaluation was carried out as
follows:
n Its shape (regular or irregular).
n Its border (well deﬁned, ill deﬁned, speculated).
n Pattern of enhancement (homogenous, heterogeneous or
ring enhancement).
n Dynamic behavior of the mass with evaluation of the initial
enhancement as well as the shape of time/signal intensity
curve (type I, type II or type III) was studied.
Diffusion-weighted images are then examined regarding the
signal intensity and the mean ADC of each lesion.
MRI BI-RADS classiﬁcation was applied for each lesion
based on the combination of morphologic and kinetic criteria
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Fig. 1 Comparison between histopathological results as regards
age.
DWI and MRI in detection and differentiation of breast lesions 261described by Fischerl et al. (11) and Sardanelli et al. (12). Find-
ings were correlated with histopathological result.
2.6. Data analysis
Data were statistically described in terms of range,
mean ± standard deviation (±SD), frequencies (number of
cases) and percentages when appropriate. Accuracy was repre-
sented using the terms sensitivity and speciﬁcity. All statistical
calculations were done using SPSS (Statistical Package for the
Social Science; SPSS Inc., Chicago, IL, USA) version 15 for
Microsoft Windows.
3. Results
The present study included 30 patients with mean age of
47 ± 10.5 and age range of 24–76 years. The mean age of
patients with benign lesions was 49 ± 5.7, whereas, the mean
age of patients with malignant lesions was 47 ± 12.1, (Table 1
and Fig. 1).
Among the included 30 patients, 26 patients (86.67%) pre-
sented with a single lesion and 4 patients (13.33%) presented
with multiple lesions.
The study is formed of 12 patients (40%) who came with
ﬁrst time breast symptoms while the remaining 18 patients
(60%) were in follow up following breast cancer surgery and
management.
Regarding the site of the detected lesions, the malignant
lesions were retro-areolar in 5 patients (25%), deeply seated
in 7 patients (35%), upper outer quadrant in 4 patients
(20%), at operative bed in 1 patient (5%), lower outer quad-
rant in 1 patient (5%) and lower inner quadrant in 2 patients
(10%).
Alternatively, the benign lesions were retro-areolar in 1
patient (6.67%), deeply seated in 3 patients (20%), upper outer
quadrant in 6 patients (40%), all the breast in 2 patients
(13.33%), lower outer quadrant in 1 patient (6.67%) and
axillary bed in 2 patients (13.33%) (Table 2 and Fig. 2).
According to the histopathological analysis, there were 20
malignant lesions (57.14%) and 15 benign lesions (42.86%).
The histopathological types are presented in Table 3 and Fig. 3.
3.1. MRI BI-RADS of benign and malignant lesions
The detected 35 breast lesions classiﬁed according to MRI BI-
RADS scoring were: 7 lesions assigned for MRI BI-RADS 2
were benign lesions, 8 lesions were assigned for MRI BI-
RADS 3; 4 lesions were malignant and 4 lesions were benign,
13 lesions were assigned for MRI BI-RADS 4; 9 lesions were
malignant and 4 lesions were benign, 7 lesions assigned for
MRI BI-RADS 5 were malignant lesions (Table 4 and Fig. 4).Table 1 Comparison between histopathological results as
regards age.
Age t-Test
Min. Max. Mean ±SD t p-Value
Malignant 24.00 76.00 47.00 12.08 0.052 0.823 (NS)
Benign 45.00 53.00 49.00 5.66Regarding appearance of lesion in MRI T2 weighted image,
the lesions were low signal in 12 malignant lesions and 8
benign lesions, intermediate signal in 6 malignant lesions and
3 benign lesions and high signal in 2 malignant lesions
(Phyllodes cystosarcoma and inﬂammatory carcinoma) and 3
benign lesions.
Regarding the shape of the lesion, the shape was diffuse in 6
malignant lesions and 2 benign lesions, oval in 4 malignant
lesions and 6 benign lesions. In addition the shapes were
round, irregular in (7) (2), (3) (5) malignant lesions and benign
lesions respectively.
Considering the margin of the lesions detected, ill-deﬁned
margin was seen in 21 lesions (60%); 14 lesions (66.67%) were
malignant and 7 lesions (33.33%) were benign. On the other
hand, well-deﬁned margin was noted in 14 (40%) lesions; 6
(42.86%) lesions were malignant and 8 (57.14%) lesions were
benign.
Considering the pattern of contrast enhancement, Rim
enhancement was noted in 7 lesions; 5 lesions were malignant
and 2 lesions were benign. On the other hand, heterogeneous
enhancement was noted in 11 lesions; 10 lesions were malig-
nant and 1 lesion was benign. In addition, homogenous
enhancement was noted in 12 lesions; 5 lesions were malignant
and 7 lesions were benign, and non enhancement in 5 benign
lesions.
Regarding the type of dynamic curve (time/signal intensity
curve), type 3 (wash out) was noted in 13 malignant lesions.
Type 2 (plateau) was noted in 7 malignant lesions and 7 benign
lesions while type 1 (progressive rising) was noted in 8 benign
lesions (Table 5 and Fig. 5).
DCE-MRI had a sensitivity of 80%, a speciﬁcity of
73.33%, PPV of 80%, NPV of 73.3% and accuracy of
77.14% (Fig. 6).
The malignant lesions showed a mean ADC value of
1.03 ± 0.35.
Alternatively, the benign lesion showed a mean ADC value
of 1.38 ± 0.26, (Table 6 and Fig. 7). This table shows highly
statistically signiﬁcant ADC difference between benign and
malignant lesions, with p-value <0.001 HS.
The ROC (receiver operating characteristic) curve showed
that the best ADC cut-off value to differentiate between
benign and malignant lesions was 1.2 mm2/s (P< 0.001) with
Table 2 The site and distribution of the detected breast lesions in correlation with histopathological results.
Site Malignant Benign Total
No. % No. % No. %
All the breast 0 0.00 2 13.33 2 5.71
At operative bed 1 5.00 0 0.00 1 2.86
Axillary bed 0 0.00 2 13.33 2 5.71
Deep sited 7 35.00 3 20.00 10 28.57
LOQ 1 5.00 1 6.67 2 5.71
Lower inner quadrant 2 10.00 0 0.00 2 5.71
Retro areolar 5 25.00 1 6.67 6 17.14
UOQ 4 20.00 6 40.00 10 28.57
Total 20 100.00 15 100.00 35 100.00
0
5
0
35
5
10
25
20
13.33
0
13.33
20
6.67
0
6.67
40
0
5
10
15
20
25
30
35
40
45
All the
breast
At
operative
bed
Axillary
bed
Deep
sited
LOQ Lower
inner
Quadrant
Retro
areolar
UOQ
Malignant Benign%
Fig. 2 Pie chart shows the site of total breast lesions.
Table 3 Histopathological diagnoses of the 35 examined
breast lesions.
Histopathological type No. %
Abscess 1 2.86
Cystosarcoma phylloid 1 2.86
DCI 1 2.86
Duct ectasia 1 2.86
Fat necrosis 2 5.71
Fibro adenoma 6 17.14
Fibrotic scar 6 17.14
IDC 6 17.14
ILC 5 14.29
Inﬂammatory carcinoma 2 5.71
LCI 1 2.86
Lobular carcinoma in situ 2 5.71
Mastitis 1 2.86
Total 35 100.00
262 W. Hettasensitivity, speciﬁcity, PPV, NPV and accuracy of 85%,
93.33%, 94.4%, 82.4% and 90.3% respectively (Fig. 8).
Among the 20 malignant lesions, 17 lesions showed an
ADC value 61.20 mm2/s and 3 lesions showed an ADC value
>1.20 mm2/s. While among the 15 benign lesions, 14 lesionsshowed ADC value >1.20 mm2/s and 1 lesion showed an
ADC value 61.20 (Table 7 and Fig. 9).
4. Discussion
We conducted a study of 30 patients (12 patients with ﬁrst time
breast lesions and 18 patients post operative recurrent breast
lesions) with 35 breast lesions (20 malignant and 15 benign
lesions) to evaluate the role of DWI in the detection of primary
or recurrent breast lesions.
In this study, deep sited region was the most frequent site of
malignant lesions (35.00%), followed by retro areolar site and
upper outer quadrant with 25.00% and 20.00% respectively.
The upper outer quadrant was the most frequent site of benign
lesions (40.00%), followed by deep sited region and axillary
site with 20.00% and 13.33% respectively.
This is comparable with Harirchi et al. who reported that
upper-outer quadrant was the most frequent site of malignant
lesions (39.9%), followed by peri-areolar region (18.4%), while
the most frequent site of benign lesions was upper-outer quad-
rant (32.75%), followed by axillary bed (15.3%) (13).
According to our study, the two most frequent malignant
lesions were invasive ductal carcinoma and invasive lobular
carcinoma which represented 17.14% and 14.29% respectively
while the two most frequent benign lesions were ﬁbroadenoma
and ﬁbrotic scar which represented 17.14% and 17.14%
respectively.
On the other hand, Li et al. showed in their breast lesions
survey that invasive ductal carcinoma account for 56%, ﬁbro-
adenoma in 20% and invasive lobular carcinoma in 10% only
(14).
Appearance of the lesions in T2 weighted image in this
study was almost either low or intermediate signal intensity
which is similar to the result of a study conducted by Kuhl
et al. who found that 87% of lesions in their study were either
low or intermediate signal to the adjacent glandular tissue (15).
Shape of the malignant lesions in this study was variable
with a predominant round and diffuse pattern in 7 and 6
lesions respectively, while benign lesions were oval and irregu-
lar in shape in 6 and 5 lesions respectively.
Al-Khawari et al. and Tozaki et al. showed in their studies
that most malignant lesions had diffuse and irregular shape
while benign lesions had round or oval shape (16,17).
In our study, we found ill deﬁned & speculated margins in
21 mass lesions, 7 of them were benign and 14 lesions were
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Fig. 3 Pie chart shows the histopathological diagnoses of the 35 examined breast lesions.
Table 4 MRI BI-RADS of benign and malignant breast
lesions.
BIRADs Malignant Benign Total
No. % No. % No. %
II 0 0.00 7 46.67 7 20.00
III 4 20.00 4 26.67 8 22.86
IV 9 45.00 4 26.67 13 37.14
V 7 35.00 0 0.00 7 20.00
Total 20 100.00 15 100.00 35 100.00
DWI and MRI in detection and differentiation of breast lesions 263malignant, there were 14 well deﬁned mass lesions; 8 of them
were benign and 6 lesions were malignant.
This is comparable with Al-Khawari et al. who reported
that most malignant lesions showed ill deﬁned margin while
benign lesion showed well deﬁned margin. They also reported
that the value of morphologic criteria in the form of shape and
margin of the lesion to describe MRI-detected breast lesions0
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Fig. 4 Pie chart shows the histopathological dhas been limited by the lack of a deﬁnitive classiﬁcation scheme
(16).
In our study regarding pattern of enhancement, heteroge-
neous enhancement was seen in 11 lesions, rim in 7 lesions,
homogenous in 12 lesions and non enhancement in 5 lesions.
However, Tozaki et al. reported that the most frequent
morphological ﬁnding among the lesions was heterogeneous
and rim internal enhancement with a percentage of 45% and
30% respectively (17).
In our study, the sensitivity and speciﬁcity of DCE-MRI
examination were 80% and 73.33% respectively, this was
based on the combination of morphologic and kinetic criteria
described by Fischerl et al. (18) and Sardanelli et al. (12).
We disagree with Gianfelice et al. who reported that sensi-
tivity and speciﬁcity of DCE-MRI were 90% and 67% respec-
tively (19).
Drew et al. reported that sensitivity and speciﬁcity of DCE-
MRI were 90% and 76% respectively (20).55
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iagnoses of the 35 examined breast lesions.
Table 5 The type of curve & distribution of the detected
breast lesions in correlation with histopathological results.
Type Groups Total
Malignant Benign
No. % No. % No. %
I 0 0.00 8 53.33 8 22.86
II 7 35.00 7 46.67 14 40.00
III 13 65.00 0 0.00 13 37.14
Total 20 100.00 15 100.00 35 100.00
v2 20.71
p-Value <0.001 (HS)
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Fig. 5 Pie chart shows the type of curve & distribution of the
detected breast lesions in correlation with histopathological
results.
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Fig. 6 A receiver operating characteristic (ROC curve) for
DCE-MRI to differentiate between benign and malignant breast
lesions.
Table 6 Comparison between histopathological results as
regards ADC.
Histopathological ADC t-Test
Min. Max. Mean ±SD t p-Value
Malignant 0.50 1.80 1.03 0.35 3.399 <0.001
Benign 1.13 1.95 1.38 0.26
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Fig. 7 Bar chart shows the mean ADC values of benign and
malignant lesions.
Fig. 8 A receiver operating characteristic (ROC curve) analysis
for the ADC value to differentiate between benign and malignant
breast lesions.
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Table 7 The distribution of benign and malignant lesions according to the best cut off value.
ADC Malignant, n (%) Benign, n (%) Total, n (%)
Below cut oﬀ 61.2 mm2/s 17 (85%) 1 (6.67%) 18 (51.43%)
Above cut oﬀ >1.2 mm2/s 3 (15%) 14 (93.33%) 17 (84.57%)
Total 20 (100%) 15 (100%) 35 (100%)
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0.00
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50.00
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80.00
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Below cut off  1.2 mm 2/s Above cut off >1.2 mm 2 /s%
Fig. 9 Bar chart shows distribution of benign and malignant
lesions according to the best ADC cut off value.
DWI and MRI in detection and differentiation of breast lesions 265In our study after evaluating the morphologic characteris-
tics of each lesion, we assessed the dynamic behavior using
quantitative analysis of signal intensity [measured by means
of computer manipulated region of interest (ROI)] as well as
type of the time/signal intensity curve.
Among benign lesions, type 1 curve was obtained in 8
lesions; type 2 curve in 7 lesions while no lesion had been
detected showing type 3 curves.
Among malignant lesions, type 1 curve was not obtained in
any malignant lesion, type 2 in 7 lesions and type 3 in 13
lesions.
This is in agreement with many studies that reported the
importance of the curve shape in differentiating between
malignant and benign lesions. Type III curve is more suspi-
cious for malignancy (21), whereas progressive rising curves
are associated with benign lesions (21). Plateau curves are
indicative of either malignant or benign lesions (22).
In this study, DWI had a sensitivity of 85% and speciﬁcity
of 93.33%, whereas, DCE-MRI had a sensitivity of 80% and a
speciﬁcity of 73.33%.
Kul (2011), reported 94.4% sensitivity and 84.4% speciﬁc-
ity of DWI in the characterization of lesions with ADC cut off
0.90 mm2/s (23). Tozaki and Maruyama achieved a speciﬁcity
of 67% and sensitivity of 97% for lesions with ADC cut off
1.10 mm2/s (24).
Our ﬁndings for lesions showed that the best ADC cut off
value to differentiate between benign and malignant lesionswas 1.20 mm2/s. Malignancy exhibited lower mean ADC
values compared with those of benign lesions being
1.03 · 103 mm2/s and 1.38 · 103 mm2/s respectively.
Comparable with Rubesova et al. in their study, they found
that the threshold between malignant and benign lesions for
highest sensitivity and speciﬁcity (both 86%) was around
1.13 · 103 mm2/s (25).
Similarly, Imamura et al. reported that the most feasible
ADC value to depict malignant lesions was found to be less
than 1.10 · 103 mm2/s. Using this threshold sensitivity &
speciﬁcity were 68.8 and 72.7 respectively (26).
Also, Yabuuchi et al. demonstrated an ADC value less than
1.30 · 103 mm2/s as the strongest indicator of malignancy
(27).
This difference in ADC threshold can be explained by dif-
ference in many technical variables that can affect the ADC
values, such as different MRI units, pulse sequences, or b-val-
ues (26).
Palle and Reddy (2009) found that the ADC value obtained
with low b-values (0 and 150 s/mm2) is higher than that
obtained with higher b-values (499 and 1500 s/mm2) for all
lesion types due to contribution of main perfusion effects to
the ADC. Therefore, we calculated the ADC value with high
b-values (800) to avoid the signal attenuation caused by perfu-
sion effects at low b-values (28).
We also agree with Liu et al., who reported that
DWI has higher sensitivity and speciﬁcity than those of
DCE-MRI in the characterization of breast lesion enhance-
ment (29).
Conﬂict of interest
None.Appendix A. Cases
A.1. Case (1)
History: A 47 years old female complained of right breast
tenderness with No history of previous breast surgeries
(Fig. A.1).
This lesion is associated with marked skin thickening with
No malignant axillary lymph node enlargement seen.
MRI diagnosis: Using MRI scoring system, the ﬁndings are
keeping with BI-RADS 4; suspicious for malignancy.
Histopathological diagnosis: Invasive ductal carcinoma.
Fig. A.1 The right breast shows bilobed, ill deﬁned margin mass (arrowed) is seen in the retro-areolar region. The lesion exhibits
isointense signal intensity in T2 (a), high signal intensity in STIR (b) and irregular rim post contrast enhancement (c). The lesion displays
restricted diffusion apart from its centre with measured ADC value of 0.5 · 103 (d). The dynamic initial enhancement is medium and the
dynamic post contrast curve is of type 2 (e).
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Fig. A.2 Most of the right breast parenchyma is seen replaced by a diffuse non-mass lesion (arrowed) with ill-deﬁned margin. The lesion
extends deeply. The lesion exhibits low signal at T2 (a), inhomogeneous post contrast enhancement (b). The lesion displays restricted
diffusion with measured ADC value of 1.1 · 103 (c).The dynamic initial enhancement is medium and the dynamic post contrast curve is
of type 3 (d).
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Fig. A.3 As regards the right breast small simple cyst is seen at about 6 o’clock position with diffusion restriction and ADC value
1.82 · 103 cm/s (d), yielded type 1 curve (e).
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Fig. A.4 The right breast shows well deﬁned solid lesion at deep central portion of the breast about 5 cm from the nipple. The lesion
exhibits mixed signal on T2WI&STIR (a and b), there is lobulated outline with homogenous post contrast enhancement (c), no diffusion
restriction with ADC of the lesion is 1.9 · 103 cm/s (d). Dynamic curve with ROI plotted on the right breast lesion show type 1 curve (e).
DWI and MRI in detection and differentiation of breast lesions 269A.2. Case (2)
History: A 51 years old female complained of right breast
lump with No history of previous breast surgeries (Fig. A.2).
This lesion is associated with marked skin thickening with
No malignant axillary lymph node enlargement seen.MRI diagnosis: Using MRI scoring system, the ﬁndings
are keeping with BI-RADS 4: Highly suggestive for
malignancy.
Histopathological diagnosis: Invasive lobular carcinoma.
270 W. HettaA.3. Case (3)
History: A47 year old female aknown case of left breast cancer
underwent lumpectomy followed by CTH (Fig. A.3).
As regard the left breast: 2 fat containing lesions are
seen.
One at about 1 o’clock position near surgical scar with
peripheral rim irregular enhancement (c) yielded type 1 curve
(f), with no diffusion restriction (d).
The other one is seen at axillary tail which shows hetroge-
nous appearance(c) with no diffusion restriction and ADC
value 1.32 · 103 cm/s (d).
Normal skin and subcutanceous tissue, with no abnormal
L.N.
MRI Dx: using MRI scoring system, right breast small sim-
ple cyst BIRADs (2).
Left breast benign looking 2 fat containing focal lesions
likely representing fat necrosis BIRADs (3).
Histopathological Dx: Left breast fat necrosis.
A.4. Case (4)
History: A55years old female complain of right breast lump
with no history of previous surgery (Fig. A.4).
The lesion display normal skin and subcutance tissue thick-
ness with no evidence of abnormal L.N.
MRI Dx: using MRI scoring system, it is of BIRADs (3).
Histopathological Dx: Fibroadenoma.
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